C9orf72
C9orf72 repeat expansions are a leading genetic cause of ALS and frontotemporal dementia, linking a non-coding structural variant to neurodegeneration.
Key Takeaways
- •C9orf72 repeat expansion is the most common genetic cause of ALS and FTD in many populations.
- •Expansion biology involves repeat RNA foci, toxic dipeptide repeat proteins, and reduced C9orf72 protein function.
- •Downstream pathology often includes TDP-43 aggregation, linking C9orf72 to shared ALS and FTD mechanisms.
- •Therapeutic strategies include antisense approaches targeting repeat RNA and interventions targeting DPR toxicity.
Basic Information
- Gene Symbol
- C9orf72
- Full Name
- C9orf72-SMCR8 Complex Subunit
- Also Known As
- C9-ALS/FTDC9
- Location
- 9p21.2
- Protein Type
- Autophagy and immune regulator
- Protein Family
- C9orf72 complex
Related Isoforms
Key SNPs
Hexanucleotide repeat expansion in C9orf72 is the most common genetic cause of ALS and FTD in many populations.
SNP associated with the C9orf72 risk haplotype that predisposes to expansion events in some lineages.
Pathogenic expansions are much larger than typical repeat lengths and can vary by tissue and generation.
Expanded repeat RNA can form nuclear foci that sequester RNA-binding proteins.
Repeat-associated non-ATG translation produces dipeptide repeat proteins that contribute to toxicity.
Reduced C9orf72 protein can impair autophagy and immune homeostasis, contributing to vulnerability.
Repeat size can vary across tissues, complicating measurement and genotype-phenotype relationships.
Overview
C9orf72 is best known clinically for a GGGGCC hexanucleotide repeat expansion that is a major genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. The repeat expansion sits in a non-coding region and triggers several parallel mechanisms of toxicity.
Mechanisms include repeat RNA foci that sequester RNA-binding proteins, repeat-associated translation into toxic dipeptide repeat proteins, and reduced C9orf72 protein function that can impair autophagy and immune homeostasis. Many cases converge downstream on TDP-43 pathology, linking C9orf72 to shared ALS and FTD pathways.
Conceptual Model
A simplified mental model for the pathway:
C9orf72 biology is multi-mechanistic, so therapeutic approaches often target repeat RNA, DPR proteins, or downstream convergence points such as TDP-43 and autophagy.
Core Health Impacts
- • Dopamine regulation: Regulates the supply and release of dopamine.
- • Vesicle homeostasis: Maintains synaptic vesicle pool homeostasis.
- • Mitochondrial efficiency: Influences mitochondrial respiratory efficiency.
- • Nuclear signaling: Modulates DNA repair and gene transcription in the nucleus.
- • Chaperone activity: Acts as a molecular chaperone for SNARE complex assembly.
Protein Domains
N-Terminal (Amphipathic)
Contains the KTKEGV repeats. This region forms an alpha-helix upon binding to phospholipid membranes and contains most known familial mutations.
NAC Domain
The "Non-Amyloid-beta Component" is highly hydrophobic and essential for protein aggregation.
C-Terminal (Acidic)
Highly charged and unstructured region. It is a hotspot for post-translational modifications, including phosphorylation at Ser129.
Upstream Regulators
Repeat expansion Activator
Expanded GGGGCC repeats initiate RNA foci, DPR production, and downstream stress signaling.
RAN translation Activator
Repeat-associated translation produces DPR proteins that can disrupt nucleocytoplasmic transport.
RBP sequestration Activator
Expanded repeat RNA can sequester RBPs, altering splicing and transcript stability.
Nuclear transport stress Activator
Transport defects amplify vulnerability and can interact with TDP-43 pathology.
Autophagy-lysosome impairment Activator
Reduced C9orf72 complex function can impair autophagy initiation and lysosomal pathways.
Neuroinflammation Activator
Microglial and immune dysregulation can amplify neurodegeneration.
Downstream Targets
RNA foci Activates
Repeat RNA foci can disrupt RNA processing by sequestering RBPs.
DPR protein toxicity Activates
DPR proteins can disrupt ribosomes, nucleoli, membranes, and nuclear transport.
TDP-43 pathology Activates
Many C9orf72 cases show downstream TDP-43 aggregation and nuclear depletion.
Autophagy defects Activates
C9orf72 complex function intersects with autophagy initiation and lysosomal trafficking.
Synaptic failure Activates
Network dysfunction and synaptic loss emerge from combined RNA and inflammatory stress.
Motor and frontal networks Activates
Selective vulnerability affects motor neurons and frontal-temporal circuits.
Role in Aging
Aging increases vulnerability to repeat expansion toxicity by reducing proteostasis capacity, weakening nuclear transport, and increasing neuroinflammatory tone. These shifts can amplify RNA foci effects, DPR protein stress, and downstream TDP-43 pathology.
Proteostasis decline
Reduced autophagy and proteasome capacity increases persistence of DPR proteins and stress granule remnants.
Energy stress
Mitochondrial aging increases vulnerability to proteotoxic stress and can amplify downstream neurodegeneration pathways.
Lysosomal bottleneck
Reduced lysosomal function limits clearance of aggregates and can worsen autophagy deficits.
Sleep and clearance
Poor sleep can increase inflammatory tone and reduce waste clearance, amplifying stress.
Nuclear transport drift
Aging-related nuclear transport changes can interact with DPR toxicity and promote aggregation.
Inflammaging
Chronic low-grade inflammation can amplify microglial activation and accelerate network degeneration.
Disorders & Diseases
Amyotrophic Lateral Sclerosis
C9orf72 repeat expansion is a common cause of ALS. Phenotypes can include bulbar onset and cognitive changes.
Frontotemporal Dementia
C9orf72 expansions commonly cause behavioral variant FTD and language phenotypes.
ALS-FTD Spectrum
Shared molecular and network vulnerability links motor and frontal-temporal circuits.
Immune and Autophagy Dysregulation
Reduced C9orf72 protein function can alter microglial homeostasis and autophagy.
Functional Decline
ALS progression is tracked with functional scales, respiratory measures, and NfL biomarkers.
Interventions
Supplements
May support inflammation balance and membrane health.
Redox support and glutathione precursor studied in neurodegeneration contexts.
Supports sleep quality and excitability balance, affecting stress vulnerability.
Immune-modulating hormone with associations to inflammation control.
Energy-buffering compound studied for neuromuscular support.
Lifestyle
Tracking respiratory function supports timely planning and interventions in ALS.
Maintains function and reduces secondary complications from weakness.
Maintaining nutrition supports resilience; dysphagia requires proactive planning.
Sleep quality influences stress and inflammation, intersecting with vulnerability.
Medicines
Standard ALS therapy that modestly slows progression in some patients.
Antioxidant therapy used in ALS in some settings.
Treat spasticity, cramps, saliva, mood, and sleep issues to support function.
Approaches include antisense oligonucleotides targeting repeat RNA.
Lab Tests & Biomarkers
Genetic Testing
Detects the GGGGCC hexanucleotide repeat expansion in suspected ALS-FTD cases.
Panels may include C9orf72, TARDBP, SOD1, FUS, and other associated genes.
Fluid Biomarkers
Non-specific marker of axonal injury used for prognosis tracking in ALS and FTD.
Direct biomarkers for DPR proteins and repeat RNA are an active research area.
Clinical/Physiology
Functional rating scale commonly used to track ALS progression over time.
Function tests guide planning and timing of supportive interventions.
Hormonal Interactions
Cortisol Stress Factor
Chronic elevation can worsen sleep and amplify inflammatory signaling.
Thyroid hormone Metabolic Regulator
Dysfunction can worsen fatigue and weakness.
Insulin Metabolic Intersection
Systemic metabolic health influences inflammation and stress pathways.
Testosterone Body Composition
Hormonal status influences muscle mass and recovery.
Estrogen Neuroimmune
Sex hormones influence immune tone and may modulate neuroinflammation.
Melatonin Circadian
Supports sleep architecture, linked to stress resilience.
Deep Dive
Network Diagrams
C9orf72 Expansion Mechanisms
Autophagy and Immune Effects
Repeat Expansion Toxicity: Three Parallel Mechanisms
C9orf72 repeat expansions produce disease through a combination of repeat RNA toxicity, DPR protein toxicity, and reduced C9orf72 protein function. These mechanisms can converge on nuclear transport stress, proteostasis overload, and downstream TDP-43 pathology.
RNA foci: Expanded repeat RNA can accumulate in nuclear foci and sequester RNA-binding proteins.
DPR proteins: RAN translation produces dipeptide repeat proteins that disrupt cellular compartments and stress responses.
Haploinsufficiency: Reduced C9orf72 protein can impair autophagy and immune homeostasis, shaping vulnerability and progression.
Autophagy-Immune Intersection
C9orf72 protein participates in a complex that supports autophagy and endolysosomal trafficking. Reduced function can impair aggregate handling and alter microglial homeostasis, which can amplify neurodegenerative cascades in ALS and FTD.
Aggregate handling: Autophagy deficits increase persistence of DPR proteins and other misfolded species.
Microglia: Immune dysregulation can amplify cytokine loops and change phagocytic balance in vulnerable circuits.
Downstream Convergence on TDP-43
Despite distinct upstream mechanisms, many C9orf72 expansion cases converge on TDP-43 pathology. This convergence helps explain overlap between C9orf72 and other ALS-FTD genes that affect RNA processing and nuclear transport.
This convergence also shapes biomarker strategies and may define shared downstream targets across genetic subtypes.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Discovery paper identifying the C9orf72 repeat expansion as a cause of ALS and FTD.
Independent discovery confirming the C9orf72 expansion.
Showed antisense transcription and dipeptide repeat protein production.
Demonstrated dipeptide repeat protein toxicity and identified stress pathways.
Linked C9orf72 protein function to autophagy and lysosomal pathways.